Exploring RNA-based technology, its achievements, its future promises, and what it means for European healthcare: This was the aim of this year's STOA Annual Lecture, the 20th edition of a yearly event organised by the European Parliament's Panel for the Future of Science and Technology (STOA).

 

As its keynote lecturer, STOA welcomed Professor Özlem Türeci, co-founder and Chief Medical Officer of the German biotechnology company BioNTech. Together with Pfizer, BioNTech developed one of the most effective vaccines against Covid-19. But the possible applications of the RNA-based technology beyond vaccines are vast and its future is incredibly promising.

 

Watch our interview with Prof. Özlem Türeci.

 

 

Useful link:

 

• STOA annual lecture: the future of RNA-based technology

 

• STOA youtube channel